Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis

about

Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis

Item

http://www.wikidata.org/entity/Q56910156

description

article

@en

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@en

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@nl

type

Item

label

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@en

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@nl

prefLabel

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@en

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@nl

P1476

Tenofovir and tenofovir-diphos ...... g oral preexposure prophylaxis

@en

P2093

Craig W Hendrix

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Jessica E Haberer

http://www.w3.org/2001/XMLSchema#string

Katherine K Thomas

http://www.w3.org/2001/XMLSchema#string

Kenneth Mugwanya

http://www.w3.org/2001/XMLSchema#string

Maria Pyra

http://www.w3.org/2001/XMLSchema#string

Mark A Marzinke

http://www.w3.org/2001/XMLSchema#string

Nelly R Mugo

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

Renee Heffron

http://www.w3.org/2001/XMLSchema#string

P2860

Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review

Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.

Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection

High rates of HIV seroconversion in pregnant women and low reported levels of HIV testing among male partners in Southern Mozambique: results from a mixed methods study.

Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial

Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation.

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants

P304

1891-1898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001922

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29894385

http://www.w3.org/2001/XMLSchema#string

P921

immunology

7bèla

infectious disease

P932

6061961

http://www.w3.org/2001/XMLSchema#string